Mustang Bio
MBIO
93 hedge funds and large institutions have $75.3M invested in Mustang Bio in 2020 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 6 closing their positions.
300% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 6
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
55% more capital invested
Capital invested by funds: $48.4M → $75.3M (+$26.8M)
27% more call options, than puts
Call options by funds: $2.25M | Put options by funds: $1.77M
24% more funds holding
Funds holding: 75 → 93 (+18)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.23M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$2.27M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.92M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.5M |
| 5 |
Millennium Management
New York
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.69M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$894K |
| 3 |
Renaissance Technologies
New York
|
-$715K |
| 4 |
Two Sigma Advisers
New York
|
-$655K |
| 5 |
Two Sigma Investments
New York
|
-$574K |
MBIO Hedge Fund Activity: Q4 2020 in Review
93 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q4 2020, worth a combined $75.3M — up 55% from $48.4M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new MBIO positions and 6 closed out — a net gain of 18 holders — while 36 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, adding an estimated $3.23M. The largest seller was Endurant Capital Management, cutting an estimated $1.69M.
- 93 institutional investors held Mustang Bio (MBIO) as of Q4 2020, up from 75 in Q3 2020.
- Funds reported $75.3M of Mustang Bio stock for Q4 2020, up 55% quarter-over-quarter.
- 24 funds opened new Mustang Bio positions in Q4 2020 and 6 closed out, a net change of +18 holders.
- The largest Mustang Bio buyer in Q4 2020 was BlackRock, an estimated $3.23M added.
- The largest Mustang Bio seller in Q4 2020 was Endurant Capital Management, an estimated $1.69M sold.
Based on aggregated 13F filings for Q4 2020.